These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25878778)

  • 41. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
    Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The serum lipids levels may be underestimated in patients on hemodialysis.
    Ueno T; Doi S; Nakashima A; Yokoyama Y; Doi T; Kawai T; Kusano Y; Ueda C; Masaki T
    Intern Med; 2015; 54(8):887-94. PubMed ID: 25876568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
    J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of oral L-carnitine supplementation on the lipid profiles of hyperlipidaemic children.
    Güneş B; Yalçin SS; Kalkanoğlu HS; Onol S; Dursun A; Coşkun T
    Acta Paediatr; 2005 Jun; 94(6):711-6. PubMed ID: 16188773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients.
    Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M
    Nephron; 1989; 51(2):237-42. PubMed ID: 2915763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine.
    Nishimura M; Tokoro T; Takatani T; Sato N; Nishida M; Hashimoto T; Yamazaki S; Kobayashi H; Ono T
    Springerplus; 2015; 4():353. PubMed ID: 26191480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients.
    Sombolos K; Papaioannou A; Christidou F; Natse T; Bamichas G; Gionanlis L; Katsaris G; Progia E
    Int Urol Nephrol; 2006; 38(3-4):725-30. PubMed ID: 17115295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients.
    Debska-Slizień ; Kawecka A; Wojnarowski K; Prajs J; Malgorzewicz S; Kunicka D; Zdrojewski Z; Walysiak-Szydłowska ; Lipiński J; Rutkowski B
    Int J Artif Organs; 2000 Feb; 23(2):90-6. PubMed ID: 10741803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient.
    Kaneko M; Fukasawa H; Ishibuchi K; Niwa H; Yasuda H; Furuya R
    Intern Med; 2018 Dec; 57(24):3593-3596. PubMed ID: 30146554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.
    Koşan C; Sever L; Arisoy N; Calişkan S; Kasapçopur O
    Pediatr Nephrol; 2003 Nov; 18(11):1184-8. PubMed ID: 14523637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
    Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
    Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
    Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
    Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
    Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
    Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis.
    Shimizu S; Takashima H; Tei R; Furukawa T; Okamura M; Kitai M; Nagura C; Maruyama T; Higuchi T; Abe M
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.